New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
June 19, 2017 – The Medicines Company voluntarily discontinued the sale and distribution of Ionsys (fentanyl iontophoretic) transdermal system due to business reasons.
Download PDF
Return to publications
